NMTR

9 Meters Biopharma Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

NMTR price

9 Meters Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment NMTR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NMTR

Valuation

P/E

0.00

Sector -3.14

Industry -3.14

P/BV

0.00

Sector 1.75

Industry 1.75

P/Revenue (PSR)

Sector 1.94

Industry 1.94

EV/EBITDA

Sector -204.21

Industry -204.21

EV/EBIT

Sector -41.36

Industry -41.36

P/EBITDA

Sector -19.62

Industry -19.62

P/EBIT

Sector -65.94

Industry -65.94

P/Total Assets

Sector 1.04

Industry 1.04

P/Net Current Assets

Sector -9.57

Industry -9.57

P/Working Capital

Sector -123.00

Industry -123.00

EPS

-5.06

Sector -1.81

Industry -1.81

BVPS

-0.46

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

0.00%

Sector 40.72%

Industry 40.72%

EBITDA Margin

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

0.00%

Sector -35.70%

Industry -35.70%

Net Profit Margins

0.00%

Sector -36.09%

Industry -36.09%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-558.10%

Sector -59.44%

Industry -59.44%

ROA

-283.12%

Sector -60.14%

Industry -60.14%

ROIC

Sector -1,846.72%

Industry -1,846.72%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.91

Industry 2.91

Net Debt / EBITDA

Sector -20.38

Industry -20.38

Net Debt / EBIT

Sector -4.13

Industry -4.13

Net Debt / Equity

Sector -33,112.98

Industry -33,112.98

Gross Debt / Equity

Sector -0.64

Industry -0.64

Equity/Assets

-0.68

Sector 0.45

Industry 0.45

Liabilities/Assets

1.68

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

13.33%

Sector -

Industry -

Fundamentals NMTR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NMTR 9 Meters Biopharma Inc.	$0.00	-	0.00%	0.00	0.00	-558.10%	0.00%
PFE Pfizer Inc.	$30.44	36.07%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$295.11	35.26%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$39.80	-16.51%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$149.46	77.69%	2.27%	116.34	8.79	6.97%	4.77%
AZN AstraZeneca PLC	$187.27	15.68%	1.73%	22.38	5.77	27.27%	16.95%
BMY Bristol-Myers Squibb Company	$62.67	55.69%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$80.24	-43.19%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$469.71	66.32%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$912.86	40.12%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$130.85	100.51%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,005.04	25.05%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$559.48	34.10%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$253.37	55.51%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$905.64	10.18%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$38.76	32.20%	0.00%	12.39	2.25	20.46%	18.88%
BIIB Biogen Inc.	$254.75	72.29%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NMTR - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

54.10%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/27/2024	07/29/2024	0.20000000
Dividends	03/21/2024	04/25/2024	0.20000000
Dividends	12/22/2023	01/26/2024	0.20000000
Dividends	09/19/2023	10/26/2023	0.30000000
Dividends	06/14/2023	07/26/2023	0.30000000
Dividends	03/16/2023	04/26/2023	0.40000000
Dividends	12/23/2022	01/26/2023	0.25440000
Dividends	09/22/2022	10/26/2022	0.01280000
Dividends	06/23/2022	07/25/2022	0.25600000
Dividends	03/22/2022	04/25/2022	0.25600000
Dividends	12/23/2021	01/25/2022	0.27200000
Dividends	09/21/2021	10/25/2021	0.27200000
Dividends	06/22/2021	07/26/2021	0.27200000
Dividends	03/23/2021	04/26/2021	0.27200000
Dividends	12/15/2020	01/25/2021	0.08000000
Dividends	09/22/2020	10/26/2020	0.06400000
Dividends	06/29/2020	07/27/2020	0.04000000
Dividends	12/18/2019	01/27/2020	0.80000000
Dividends	09/17/2019	10/25/2019	0.80000000
Dividends	06/20/2019	07/25/2019	0.80000000
Dividends	03/27/2019	04/25/2019	0.80000000
Dividends	12/12/2018	01/25/2019	0.80000000
Dividends	09/25/2018	10/26/2018	0.80000000
Dividends	06/26/2018	07/26/2018	0.80000000
Dividends	03/27/2018	04/26/2018	0.80000000
Dividends	12/14/2017	01/25/2018	0.80000000
Dividends	09/21/2017	10/25/2017	0.80000000
Dividends	06/22/2017	07/25/2017	0.80000000
Dividends	03/23/2017	04/25/2017	0.80000000
Dividends	12/23/2016	01/26/2017	0.96000000
Dividends	09/22/2016	10/28/2016	0.96000000

ABOUT 9 Meters Biopharma

9 Meters Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

16 years

Founded: 2010

2016

Time since IPO - 10 years

12

Employees

9 Meters Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-6.30 million.

The company employs approximately 12 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, 9 Meters Biopharma Inc. reported $- in revenue, generating net income of $-68.76 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NMTR.

Market cap

Net worth

$-6.30 million

$-6,299,205.00

Assets

$9.31 million

$9,313,037.00

Total Shares Outstanding

13.59 million

13,591,000

Average Daily Trading Volume

$808.94 Thousand

$808,940.22

Sector

Health Care

Industry

Biotechnology

NMTR

NMTR revenue and profits

Financial Results NMTR

DRAG THE FRAME TO SEE MORE DATA

NMTR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,005.04 24,36% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$253.37 34,07% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

ABBV - AbbVie

$295.11 39,67% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$149.46 78,93% (12M)

P/E

116.34

2.27%

ROE

6.97%

P/BV

8.79

AZN - AstraZeneca

$187.27 16,56% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.44 32,16% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

$62.67 42,48% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,005.04 24,36% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$253.37 34,07% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

ABBV - AbbVie

$295.11 39,67% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$149.46 78,93% (12 M)

P/L

116.34

2.27%

ROE

6.97%

P/VP

8.79

AZN - AstraZeneca

$187.27 16,56% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.44 32,16% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

$62.67 42,48% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of 9 Meters Biopharma (NMTR) today?

The current price of 9 Meters Biopharma (NMTR) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does 9 Meters Biopharma (NMTR) pay dividends?

9 Meters Biopharma (NMTR) did not pay dividends over the past year.

Is 9 Meters Biopharma (NMTR) a good investment?

9 Meters Biopharma (NMTR) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a -4% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy 9 Meters Biopharma (NMTR) stock?

You can buy 9 Meters Biopharma (NMTR) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NMTR and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of 9 Meters Biopharma (NMTR) yield today?

Over the past month, 9 Meters Biopharma (NMTR) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of 9 Meters Biopharma (NMTR) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NMTR

9 Meters Biopharma Inc.

Asset unavailable for trading

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NMTR

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NMTR WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT 9 Meters Biopharma

9 Meters Biopharma Inc.

United States

16 years

2016

12

PROFIT X PRICE NMTR

Financial Results NMTR

NMTR cash flow

Asset, Revenue and Profit Growth - NMTR

NMTR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions